FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/23/2024
Back to search
Official data from USPTO
CIMEIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/23/2024
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
04/22/2022
Registration date
12/19/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/19/2023
Last transaction
12/19/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
PINO, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized triangle design with a circle in the middle and the stylized wording "CIMEIO THERAPEUTICS".
Holders and representatives
Holders
CIMEIO THERAPEUTICS AG
Representatives
Michael J. Leonard Fox Rothschild LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for gene and cell therapy
Class 42
Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development servicesall in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy
Class 44
Gene and cell therapy medical services; medical consultant services in the fields of gene therapy and cell therapy
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2024
FIMP
FINAL DISPOSITION PROCESSED
04/02/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/19/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/29/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2023
PUBO
PUBLISHED FOR OPPOSITION
10/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/13/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/13/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/17/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/16/2023
RFNP
REFUSAL PROCESSED BY IB
05/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/15/2023
RFRR
REFUSAL PROCESSED BY MPU
04/14/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/24/2023
CNRT
NON-FINAL ACTION WRITTEN
02/23/2023
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/22/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/18/2023
CNRT
NON-FINAL ACTION WRITTEN
02/17/2023
DOCK
ASSIGNED TO EXAMINER
02/10/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens CIMEIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.